Wayne Holman, MD

Dr. Holman is the Founder and CEO of Ridgeback Capital, co-founder of Ridgeback Biotherapeutics, and serves as Co-Chair of the Ridgeback-Merck Lagevrio (molnupiravir) Joint Steering Committee.  For over 20 years Dr. Holman has provided funding to over 100 public and private biopharma companies to facilitate the research and development of transformational medicines to help people with unmet needs.  Dr. Holman is a licensed physician and graduate of New York University School of Medicine and has an undergraduate degree in economics from Yale University.  He also serves as a member of the NYU Langone Board of Trustees and the University of Miami Board of Trustees. He lives in Miami with his wife, 4 children, and 3 dogs.